Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Open Forum Infectious Diseases|October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.
Retrovirology|September 7, 2016
Tracing HIV-1 transmission: envelope traits of HIV-1 transmitter and recipient pairsCorinna S Oberle, Beda Joos, Peter Rusert, et al.
The Lancet. Infectious Diseases|July 24, 2015
Clinical features and viral kinetics in a rapidly cured patient with Ebola virus disease: a case reportManuel Schibler, Pauline Vetter, Pascal Cherpillod, et al.
The Journal of Infectious Diseases|March 6, 2019
Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since InfectionLouisa A Carlisle, Teja Turk, Katharina Kusejko, et al.
The Lancet. Infectious Diseases|August 8, 2015
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trialAngela Huttner, Julie-Anne Dayer, Sabine Yerly, et al.
Nature Medicine|September 2, 2024
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cellsAsier Sáez-Cirión, Anne-Claire Mamez, Véronique Avettand-Fenoel, et al.
Nature Communications|November 3, 2020
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ARTChenjie Wan, Nadine Bachmann, Venelin Mitov, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2023
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1Suraj Balakrishna, Tom Loosli, Maryam Zaheri, et al.
Brain Communications|July 4, 2024
Self-reported neurocognitive complaints in the Swiss HIV Cohort Study: a viral genome-wide association studyMarius Zeeb, Chloé Pasin, Matthias Cavassini, et al.
Archives of Internal Medicine|May 28, 2003
A prospective trial of structured treatment interruptions in human immunodeficiency virus infectionCatherine Fagard, Annette Oxenius, Huldrych Günthard, et al.
Pageof 18